Insights from compassionate use of tocilizumab for COVID-19 to inform appropriate design of randomised controlled trials.

More search options...

Baker, EH; Patel, K; Ball, J; Edwards, S; Harrison, TS; Kaul, A; Koh, M; Krishna, S; Leaver, S; Kumar, V; et al. Baker, EH; Patel, K; Ball, J; Edwards, S; Harrison, TS; Kaul, A; Koh, M; Krishna, S; Leaver, S; Kumar, V; Forton, DM (2021) Insights from compassionate use of tocilizumab for COVID-19 to inform appropriate design of randomised controlled trials. Br J Clin Pharmacol, 87 (3). pp. 1584-1586. ISSN 1365-2125 https://doi.org/10.1111/bcp.14466
SGUL Authors: Baker, Emma Harriet Harrison, Thomas Stephen Krishna, Sanjeev

	Microsoft Word (.docx) Accepted Version Available under License ["licenses_description_publisher" not defined]. Download (50kB)
	Microsoft PowerPoint (Figure 1) Accepted Version Available under License ["licenses_description_publisher" not defined]. Download (1MB)

Item Type:

Article

Additional Information:

This is the peer reviewed version of the following article: Baker, E.H., Patel, K., Ball, J., Edwards, S., Harrison, T.S., Kaul, A., Koh, M., Krishna, S., Leaver, S., Kumar, V. and Forton, D.M. (2021), Insights from compassionate use of tocilizumab for COVID‐19 to inform appropriate design of randomised controlled trials. Br J Clin Pharmacol, 87: 1584-1586, which has been published in final form at https://doi.org/10.1111/bcp.14466. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.

Keywords:

Pharmacology & Pharmacy, 1115 Pharmacology and Pharmaceutical Sciences

SGUL Research Institute / Research Centre:

Academic Structure > Infection and Immunity Research Institute (INII)

Journal or Publication Title:

Br J Clin Pharmacol

ISSN:

1365-2125

Language:

eng

Dates: